Page last updated: 2024-11-07

aldosterone and Hyperlipoproteinemia Type II

aldosterone has been researched along with Hyperlipoproteinemia Type II in 2 studies

Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

Research Excerpts

ExcerptRelevanceReference
"Losartan (50 mg/day) was given to a patient with coronary heart disease who had been treated by DSC-LDL apheresis and had experienced an anaphylactoid reaction by administration of an angiotensin converting enzyme inhibitor."1.30Effects of losartan on low-density lipoprotein apheresis. ( Kojima, S; Kuramochi, M; Saotome, M; Shida, M; Tanaka, K; Yoshitomi, Y, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kojima, S1
Yoshitomi, Y1
Saotome, M1
Tanaka, K1
Shida, M1
Kuramochi, M1
Khashimov, KhA1
Vorontsov, VI1
Kurdanov, KhA1
Konovalov, GA1
Atakhanov, ShE1

Other Studies

2 other studies available for aldosterone and Hyperlipoproteinemia Type II

ArticleYear
Effects of losartan on low-density lipoprotein apheresis.
    Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 1999, Volume: 3, Issue:4

    Topics: Aldosterone; Antihypertensive Agents; Bradykinin; Combined Modality Therapy; Follow-Up Studies; Huma

1999
[Effect of plasmapheresis on plasma hormone levels in patients with hereditary hypercholesterolemia].
    Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1986, Volume: 9, Issue:1

    Topics: Adult; Aldosterone; Angiotensin I; C-Peptide; Calcitonin; Estradiol; Female; Growth Hormone; Hormone

1986